Exon skipping induces uniform dystrophin rescue with dose-dependent restoration of serum miRNA biomarkers and muscle biophysical properties

Hoffman, 1987, Dystrophin: the protein product of the Duchenne muscular dystrophy locus, Cell, 51, 919, 10.1016/0092-8674(87)90579-4 Petrof, 1993, Dystrophin protects the sarcolemma from stresses developed during muscle contraction, Proc. Natl. Acad. Sci. USA, 90, 3710, 10.1073/pnas.90.8.3710 Ervasti, 1993, A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin, J. Cell Biol., 122, 809, 10.1083/jcb.122.4.809 Aartsma-Rus, 2009, Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutations, Hum. Mutat., 30, 293, 10.1002/humu.20918 Roberts, 2020, Advances in oligonucleotide drug delivery, Nat. Rev. Drug Discov., 19, 673, 10.1038/s41573-020-0075-7 Charleston, 2018, Eteplirsen treatment for Duchenne muscular dystrophy: exon skipping and dystrophin production, Neurology, 90, e2146, 10.1212/WNL.0000000000005680 Komaki, 2018, Systemic administration of the antisense oligonucleotide NS-065/NCNP-01 for skipping of exon 53 in patients with Duchenne muscular dystrophy, Sci. Transl. Med., 10, eaan0713, 10.1126/scitranslmed.aan0713 Godfrey, 2015, How much dystrophin is enough: the physiological consequences of different levels of dystrophin in the mdx mouse, Hum. Mol. Genet., 24, 4225, 10.1093/hmg/ddv155 van Westering, 2020, Uniform sarcolemmal dystrophin expression is required to prevent extracellular microRNA release and improve dystrophic pathology, J. Cachexia Sarcopenia Muscle, 11, 578, 10.1002/jcsm.12506 Torelli, 2021, High-throughput digital image analysis reveals distinct patterns of dystrophin expression in dystrophinopathy patients, J. Neuropathol. Exp. Neurol., 80, 955, 10.1093/jnen/nlab088 Aartsma-Rus, 2015, Circulating biomarkers for duchenne muscular dystrophy, J. Neuromuscul. Dis., 2, S49, 10.3233/JND-150102 Coenen-Stass, 2017, Biomarker potential of extracellular miRNAs in duchenne muscular dystrophy, Trends Mol. Med., 23, 989, 10.1016/j.molmed.2017.09.002 Chen, 2010, microRNA-1 and microRNA-206 regulate skeletal muscle satellite cell proliferation and differentiation by repressing Pax7, J. Cell Biol., 190, 867, 10.1083/jcb.200911036 Chen, 2006, The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation, Nat. Genet., 38, 228, 10.1038/ng1725 Kim, 2006, Muscle-specific microRNA miR-206 promotes muscle differentiation, J. Cell Biol., 174, 677, 10.1083/jcb.200603008 Boutz, 2007, MicroRNAs regulate the expression of the alternative splicing factor nPTB during muscle development, Genes Dev., 21, 71, 10.1101/gad.1500707 Cacchiarelli, 2011, miRNAs as serum biomarkers for Duchenne muscular dystrophy, EMBO Mol. Med., 3, 258, 10.1002/emmm.201100133 Coenen-Stass, 2018, Comprehensive RNA-sequencing analysis in serum and muscle reveals novel small RNA signatures with biomarker potential for DMD, Mol. Ther. Nucleic Acids, 13, 1, 10.1016/j.omtn.2018.08.005 Mizuno, 2011, Identification of muscle-specific microRNAs in serum of muscular dystrophy animal models: promising novel blood-based markers for muscular dystrophy, PLoS One, 6, e18388, 10.1371/journal.pone.0018388 Roberts, 2012, Expression analysis in multiple muscle groups and serum reveals complexity in the MicroRNA transcriptome of the mdx mouse with implications for therapy, Mol. Ther. Nucleic Acids, 1, e39, 10.1038/mtna.2012.26 Roberts, 2013, Extracellular microRNAs are dynamic non-vesicular biomarkers of muscle turnover, Nucleic Acids Res., 41, 9500, 10.1093/nar/gkt724 van Westering, 2020, Mutation-independent proteomic signatures of pathological progression in murine models of duchenne muscular dystrophy, Mol. Cell. Proteomics, 19, 2047, 10.1074/mcp.RA120.002345 Goyenvalle, 2012, Rescue of severely affected dystrophin/utrophin-deficient mice through scAAV-U7snRNA-mediated exon skipping, Hum. Mol. Genet., 21, 2559, 10.1093/hmg/dds082 Vignier, 2013, Distinctive serum miRNA profile in mouse models of striated muscular pathologies, PLoS One, 8, e55281, 10.1371/journal.pone.0055281 Jeanson-Leh, 2014, Serum profiling identifies novel muscle miRNA and cardiomyopathy-related miRNA biomarkers in Golden Retriever muscular dystrophy dogs and Duchenne muscular dystrophy patients, Am. J. Pathol., 184, 2885, 10.1016/j.ajpath.2014.07.021 Coenen-Stass, 2015, Identification of novel, therapy-responsive protein biomarkers in a mouse model of Duchenne muscular dystrophy by aptamer-based serum proteomics, Sci. Rep., 5, 17014, 10.1038/srep17014 Toivonen, 2014, MicroRNA-206: a potential circulating biomarker candidate for amyotrophic lateral sclerosis, PLoS One, 9, e89065, 10.1371/journal.pone.0089065 Catapano, 2016, Altered levels of MicroRNA-9, -206, and -132 in spinal muscular atrophy and their response to antisense oligonucleotide therapy, Mol. Ther. Nucleic Acids, 5, e331, 10.1038/mtna.2016.47 Perfetti, 2014, Plasma microRNAs as biomarkers for myotonic dystrophy type 1, Neuromuscul. Disord., 24, 509, 10.1016/j.nmd.2014.02.005 Koutsoulidou, 2015, Elevated muscle-specific miRNAs in serum of myotonic dystrophy patients relate to muscle disease progress, PLoS One, 10, e0125341, 10.1371/journal.pone.0125341 van Putten, 2012, The effects of low levels of dystrophin on mouse muscle function and pathology, PLoS One, 7, e31937, 10.1371/journal.pone.0031937 Hightower, 2021, miR-486 is an epigenetic modulator of Duchenne muscular dystrophy pathologies, bioRxiv Zaharieva, 2013, Dystromirs as serum biomarkers for monitoring the disease severity in duchenne muscular dystrophy, PLoS One, 8, e80263, 10.1371/journal.pone.0080263 Zhang, 2020, Serum MyomiRs as biomarkers for female carriers of duchenne/becker muscular dystrophy, Front. Neurol., 11, 617878, 10.3389/fneur.2020.617878 Perfetti, 2016, Validation of plasma microRNAs as biomarkers for myotonic dystrophy type 1, Sci. Rep., 6, 38174, 10.1038/srep38174 Koutsoulidou, 2017, Identification of exosomal muscle-specific miRNAs in serum of myotonic dystrophy patients relating to muscle disease progress, Hum. Mol. Genet., 26, 3285, 10.1093/hmg/ddx212 Mytidou, 2021, Muscle-derived exosomes encapsulate myomiRs and are involved in local skeletal muscle tissue communication, Faseb. J., 35, e21279, 10.1096/fj.201902468RR Koutsoulidou, 2011, Expression of miR-1, miR-133a, miR-133b and miR-206 increases during development of human skeletal muscle, BMC Dev. Biol., 11, 34, 10.1186/1471-213X-11-34 Chen, 2005, Real-time quantification of microRNAs by stem-loop RT-PCR, Nucleic Acids Res., 33, e179, 10.1093/nar/gni178 Van Zwieten, 2014, Assessing dystrophies and other muscle diseases at the nanometer scale by atomic force microscopy, Nanomedicine, 9, 393, 10.2217/nnm.12.215 Puttini, 2009, Gene-mediated restoration of normal myofiber elasticity in dystrophic muscles, Mol. Ther., 17, 19, 10.1038/mt.2008.239 Hanson, 2022, Non-uniform dystrophin re-expression after CRISPR-mediated exon excision in the dystrophin/utrophin double-knockout mouse model of DMD, bioRxiv Hanson, 2021, Molecular correction of Duchenne muscular dystrophy by splice modulation and gene editing, RNA Biol., 18, 1048, 10.1080/15476286.2021.1874161 Israeli, 2016, Circulating miRNAs are generic and versatile therapeutic monitoring biomarkers in muscular dystrophies, Sci. Rep., 6, 28097, 10.1038/srep28097 Holmberg, 2014, Laminin α2 chain-deficiency is associated with microRNA deregulation in skeletal muscle and plasma, Front. Aging Neurosci., 6, 155, 10.3389/fnagi.2014.00155 Li, 2021, ActRIIB:ALK4-Fc alleviates muscle dysfunction and comorbidities in murine models of neuromuscular disorders, J. Clin. Invest., 131, 138634, 10.1172/JCI138634 Tinsley, 1998, Expression of full-length utrophin prevents muscular dystrophy in mdx mice, Nat. Med., 4, 1441, 10.1038/4033 Coenen-Stass, 2016, Selective release of muscle-specific, extracellular microRNAs during myogenic differentiation, Hum. Mol. Genet., 25, 3960, 10.1093/hmg/ddw237 Coenen-Stass, 2019, Extracellular microRNAs exhibit sequence-dependent stability and cellular release kinetics, RNA Biol., 16, 696, 10.1080/15476286.2019.1582956 Gnocchi, 2011, Uncoordinated transcription and compromised muscle function in the Lmna-null mouse model of emery-dreifuss muscular dystrophy, PLoS One, 6, e16651, 10.1371/journal.pone.0016651 Nicholson, 1986, The effect of aerobic exercise on serum creatine kinase activities, Muscle Nerve, 9, 820, 10.1002/mus.880090905 Baird, 2012, Creatine-kinase- and exercise-related muscle damage implications for muscle performance and recovery, J. Nutr. Metab., 2012, 960363 Zatz, 1991, Serum creatine-kinase (CK) and pyruvate-kinase (PK) activities in Duchenne (DMD) as compared with Becker (BMD) muscular dystrophy, J. Neurol. Sci., 102, 190, 10.1016/0022-510X(91)90068-I Wong, 1983, Heterogeneity of serum creatine kinase activity among racial and gender groups of the population, Am. J. Clin. Pathol., 79, 582, 10.1093/ajcp/79.5.582 Dugué, 2004, Detection and incidence of muscular adverse drug reactions: a prospective analysis from laboratory signals, Eur. J. Clin. Pharmacol., 60, 285, 10.1007/s00228-004-0760-1 Ikeda, 2009, MicroRNA-1 negatively regulates expression of the hypertrophy-associated calmodulin and Mef2a genes, Mol. Cell Biol., 29, 2193, 10.1128/MCB.01222-08 Betts, 2012, Pip6-PMO, A new generation of peptide-oligonucleotide conjugates with improved cardiac exon skipping activity for DMD treatment, Mol. Ther. Nucleic Acids, 1, e38, 10.1038/mtna.2012.30 Roberts, 2014, Detection and quantification of extracellular microRNAs in murine biofluids, Biol. Proced. Online, 16, 5, 10.1186/1480-9222-16-5 Roberts, 2014, Assessment of RT-qPCR normalization strategies for accurate quantification of extracellular microRNAs in murine serum, PLoS One, 9, e89237, 10.1371/journal.pone.0089237 Pfaffl, 2001, A new mathematical model for relative quantification in real-time RT-PCR, Nucleic Acids Res., 29, e45, 10.1093/nar/29.9.e45 Sader, 1995, Method for the calibration of atomic force microscope cantilevers, Rev. Sci. Instrum., 66, 3789, 10.1063/1.1145439 Sneddon, 1965, The relation between load and penetration in the axisymmetric boussinesq problem for a punch of arbitrary profile, Int. J. Eng. Sci., 3, 47, 10.1016/0020-7225(65)90019-4 Saeed, 2003, TM4: a free, open-source system for microarray data management and analysis, Biotechniques, 34, 374, 10.2144/03342mt01